BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10548951)

  • 1. [Glossopyrosis and terbinafine].
    Haneke E
    Dtsch Med Wochenschr; 1999 Oct; 124(40):1186. PubMed ID: 10548951
    [No Abstract]   [Full Text] [Related]  

  • 2. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible agranulocytosis associated with oral terbinafine for onychomycosis.
    Ornstein DL; Ely P
    J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple onychocryptosis following treatment of onychomycosis with oral terbinafine.
    Weaver TD; Jespersen DL
    Cutis; 2000 Sep; 66(3):211-2. PubMed ID: 11006857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis.
    Dominicus R; Weidner C; Tate H; Kroon HA
    Br J Dermatol; 2012 Jun; 166(6):1360-2. PubMed ID: 22136723
    [No Abstract]   [Full Text] [Related]  

  • 6. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting].
    Gerasimchuk EV; Gerasimov VV; Molchanov BA
    Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis.
    Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD
    Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154
    [No Abstract]   [Full Text] [Related]  

  • 9. Preventing complications in the diabetic patient with toenail onychomycosis.
    Anarella JJ; Toth C; DeBello JA
    J Am Podiatr Med Assoc; 2001 Jun; 91(6):325-8. PubMed ID: 11420354
    [No Abstract]   [Full Text] [Related]  

  • 10. Hair loss after terbinafine treatment.
    Richert B; Uhoda I; De la Brassinne M
    Br J Dermatol; 2001 Nov; 145(5):842. PubMed ID: 11736917
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of onychomycosis].
    Suhonen R; Karvonen J
    Duodecim; 1998; 22(114):2343-50. PubMed ID: 11757097
    [No Abstract]   [Full Text] [Related]  

  • 12. Neutropenia and pancytopenia associated with oral terbinafine.
    Kovacs MJ; Alshammari S; Guenther L; Bourcier M
    J Am Acad Dermatol; 1994 Nov; 31(5 Pt 1):806. PubMed ID: 7929931
    [No Abstract]   [Full Text] [Related]  

  • 13. Terbinafine and onychomycosis.
    Eastcott DF
    N Z Med J; 1991 Jan; 104(904):17. PubMed ID: 1826145
    [No Abstract]   [Full Text] [Related]  

  • 14. Exacerbation of systemic lupus erythematosus induced by terbinafine.
    Holmes S; Kemmett D
    Br J Dermatol; 1998 Dec; 139(6):1133. PubMed ID: 9990401
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe neutropenia associated with oral terbinafine therapy.
    Gupta AK; Soori GS; Del Rosso JQ; Bartos PB; Shear NH
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):765-7. PubMed ID: 9591825
    [No Abstract]   [Full Text] [Related]  

  • 16. [On fungus and taste].
    Backhaus E
    Lakartidningen; 2012 Dec 19-2013 Jan 8; 109(51-52):2368. PubMed ID: 23367556
    [No Abstract]   [Full Text] [Related]  

  • 17. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of pulse therapy with terbinafine tablets and topical terbinafine cream for the treatment of dermatophyte onychomycosis: a pilot study.
    Nakano N; Hiruma M; Shiraki Y; Chen X; Porgpermdee S; Ikeda S
    J Dermatol; 2006 Nov; 33(11):753-8. PubMed ID: 17073989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onychomycosis is more than a cosmetic concern.
    Park MK
    J Fam Pract; 2007 Dec; 56(12):984. PubMed ID: 18053437
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of dermatophyte onychomycosis with three pulses of terbinafine (500 mg day for a week).
    Takahata Y; Hiruma M; Shiraki Y; Tokuhisa Y; Sugita T; Muto M
    Mycoses; 2009 Jan; 52(1):72-6. PubMed ID: 18444971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.